Scientists from the A*STAR Genome Institute of Singapore (A*STAR GIS) have developed a new artificial intelligence (AI)-based method called “Fragle” that makes tracking cancer easier and faster using blood tests.
SARASOTA, Fla. and HUNTSVILLE, Ala., June 11, 2025 /PRNewswire/ — World Precision Instruments (WPI), a global leader in transepithelial electrical resistance (TEER) instrumentation, and SynVivo Inc., a pioneer in Organ-on-a-Chip (OOC) technology, today announced the commercial launch of a next-generation multiplexed TEER-on-a-Chip platform—a breakthrough solution enabling real-time, high-throughput measurement of barrier integrity in advanced Organ-on-a-Chip models.
Mapping a human cell gives researchers a view of subcellular architecture and sheds light on how cancer develops.
Researchers redesign a compact RNA-guided enzyme from bacteria, making it an efficient editor of human DNA.
Researchers at McGill University and other institutes recently carried out a study aimed at identifying biomarkers and psychosocial factors associated with the development of chronic pain conditions. Their findings, published in Nature Human Behavior, were obtained by analyzing data from a large biomedical database, namely the UK Biobank, using advanced machine learning techniques.
Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a study published today in the Journal of Clinical Investigation.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
New Liquid Biopsy Technology Offers Hope in Diagnosing One of the Deadliest Cancers at an Early Stage
Two meters of DNA is crammed into the nucleus of every human cell. Bin Zhang wants to know how gene expression works in this minuscule space.
The research team, led by Professor Minee L. Choi from the Department of Brain and Cognitive Sciences, in collaboration with University College London (UCL) and the Francis Crick Institute, discovered that the RNA-editing enzyme ADAR1 plays an important role in controlling immune responses in astrocytes, glial cells that trigger protective reactions in the brain, and demonstrated that this mechanism is critically involved in the progression of Parkinson’s disease.